AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $153.2M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.15pm 07/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 30.0¢ | Day High | 30.0¢ | Day Low | 29.5¢ | |||
| Daily Volume | 167222 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 29.5¢ | 33000 | 0 | 30.5¢ | 135777 | |
Directors & Senior Management
| Dr. Anna Motta | Group Chief Technology Officer |
| Mr. Dean Scarparolo | Financial Controller & Company Secretary |
| Ms. Eva Nordmark | Non-Executive Director |
| Mr. Grant Jonathan Mooney | Independent Non-Executive Director |
| Mr. Mark Edward James Thompson | MD & Executive Director |
| Mr. Martin John Phillips | Group Chief Executive Officer |
| Mr. Niklas Karlsson | Group Finance Director |
| Mr. Sascha Keen | Director of Corporate Finance |
| Mr. Simon Coxhell | Consultant |
| Mr. Terry Dewayne Stinson | Independent Non-Executive Chairman |
Data source: ADVFN
